Arrowstreet Capital
XBIT icon

Arrowstreet Capital’s XBiotech XBIT Stock Holding History

Arrowstreet Capital’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-26,077
Closed -$498K – 2577
2020
Q3 		$498K Sell
26,077
-57,536
-69% -$993K ﹤0.01% 2021
2020
Q2 		$1.15M Sell
83,613
-16,458
-16% -$231K ﹤0.01% 1716
2020
Q1 		$1.06M Buy
100,071
+11,266
+13% +$183K ﹤0.01% 1298
2019
Q4 		$1.66M Buy
+88,805
New +$1.14M ﹤0.01% 1193

Other funds holding XBIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CCM
CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Arrowstreet Capital's XBIT Position: Q4 2020 in Review

Arrowstreet Capital sold out of XBiotech (XBIT) in Q4 2020, closing a stake of 26,077 shares — an estimated $498K sold.

Arrowstreet Capital first reported a position in XBIT in Q4 2019 and held it in 4 quarters. The position peaked at $1.66M in Q4 2019. 66 funds tracked by Wall St. Rank hold XBIT as of Q4 2020.

  • Arrowstreet Capital reported no remaining XBiotech position as of Q4 2020 after selling out during the quarter.
  • Arrowstreet Capital sold 26,077 XBiotech shares in Q4 2020, an estimated $498K.
  • Arrowstreet Capital first reported a position in XBiotech in Q4 2019 and held it in 4 quarters.
  • Arrowstreet Capital's XBiotech position peaked at $1.66M in Q4 2019.
  • 66 funds tracked by Wall St. Rank held XBiotech as of Q4 2020.

Based on Arrowstreet Capital's 13F filing for Q4 2020, filed 12 Feb 2021.